Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1991
Report date:
1991
Reference Type:
study report
Title:
Unnamed
Year:
1991
Report date:
1991
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPP 81-3 (Acute inhalation toxicity)
Deviations:
no
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Test material form:
other: Amber liquid
Details on test material:
- Name of test material (as cited in study report):Kathon(TM) 886F biocide
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Rohm and Haas, Batch No. J59098 and 60047

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature
- Stability under test conditions: Stable
- Solubility and stability of the test substance in the solvent/vehicle: Soluble and stable
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: No

TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: Dilution in water
- Final dilution of a dissolved solid, stock liquid or gel: 0.19, 0.32, 0.50, 1.26, 2.24, and 3.02 mg/L

FORM AS APPLIED IN THE TEST (if different from that of starting material)
Aerosol

OTHER SPECIFICS: 13.71 % a.i. (Batch No. J59098) and 13.99 % a.i. (Batch No. 60047)

Test animals

Species:
rat
Strain:
other: Crl:CD BR
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Kingston, Stone Ridge, New York, USA
- Age at study initiation: Not reported
- Weight at study initiation: Body weights were 184 to 230 grams for males and 193 to 230 grams for females.

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose only
Vehicle:
air
Mass median aerodynamic diameter (MMAD):
2.7 µm
Geometric standard deviation (GSD):
3.8
Remark on MMAD/GSD:
Mean respirable fraction = 57 + 9 %
The fraction of aerosol <= 1 micrometer averaged 26 % for the 0.19, 0.32 and 0.50 mg/L concentrations and averaged 18 % for the 1.26, 2.24 and 3.02 mg/L concentrations
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Plexiglas® and stainless steel chamber with up to 3 nebulizers
- Exposure chamber volume: 240 L
- Method of holding animals in test chamber: Not described
- Source and rate of air: Conditioned air
- Method of conditioning air: Air was drawn through an absolute filter
- System of generating particulates/aerosols: Nebulizer
- Method of particle size determination: Gravimetrically, by drawing samples of the chamber atmosphere through a QCM Cascade Impactor
- Treatment of exhaust air: Not described
- Temperature, humidity, pressure in air chamber: The mean chamber atmospheric temperature was 67 ± 2 °F (circa 19 °C) and the mean chamber humidity was 74 ± 5 %.

TEST ATMOSPHERE
- Brief description of analytical method used:
- Samples taken from breathing zone: no

VEHICLE
- Composition of vehicle (if applicable):
- Concentration of test material in vehicle (if applicable):

TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: Mean respirable fraction = 57 + 9 %. The fraction of aerosol <= 1 micrometer averaged 26 % for the 0.19, 0.32 and 0.50 mg/L concentrations and averaged 18 % for the 1.26, 2.24 and 3.02 mg/L concentrations.
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 2.7 micrometer / 3.8
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
Analytical concentration: 0.19, 0.32, 0.50, 1.26, 2.24, and 3.02 mg/L
No. of animals per sex per dose:
6
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical observations during exposure and twice per day for 14 days after exposure (except holidays and weekends). Body weights recorded at days 0, 1, 7 and 14. Necropsy on found dead and on survivors at day 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, histopathology
Statistics:
A SAS probit regression analysis program was used to calculate LC50, slope and confidence limits.

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male/female
Dose descriptor:
LC50
Effect level:
2.36 mg/L air
Based on:
test mat.
95% CL:
>= 1.6 - <= 4.82
Exp. duration:
4 h
Key result
Sex:
male/female
Dose descriptor:
LC50
Effect level:
0.33 mg/L air
Based on:
act. ingr.
95% CL:
>= 0.22 - <= 0.67
Exp. duration:
4 h
Mortality:
n/a
Clinical signs:
other: Signs of respiratory irritation, including gasping, rales, hyperpnea, dyspnea and vocalization, were seen in some animals in all groups immediately post-exposure. The number of animals showing these signs and the severity of the respiratory irritation cor
Body weight:
n/a
Gross pathology:
Animals in groups 4, 5 and 6 showed stomachs and/or intestines filled with gas which correlated with the concentration of the test material to which the animals were exposed, the greater response was seen in
animals exposed to the greater concentration of the test material. This was judged to be the result of swallowing air in an attempt to breathe. No other treatment-related necropsy observations were seen in any animal.

Any other information on results incl. tables

Dose (mg/L)

Number of dead /
number of investigated

Time of death (range)

0.19

0/12

No deaths

0.32

1/12

1 died within 3 h after removal from chamber

0.50

0/12

No deaths

1.26

3/12

1 died within 3 h after removal from chamber, 2 died within 24 h

2.24

4/12

3 died within 3 h after removal from chamber, 1 died within 24 h

3.02

9/12

8 died within 3 h after removal from chamber, 1 died within 24 h

LC50value

Combined male and female LC50= 2.36 mg Kathon™ 886F per liter of air.

 

 

Combined male and female LC50= 0.33 mg a.i. per liter of air.

Applicant's summary and conclusion

Interpretation of results:
Category 2 based on GHS criteria
Conclusions:
Combined male and female LC50 = 2.36 mg Kathon™ 886F per liter of air. Combined male and female LC50 = 0.33 mg a.i. per liter of air.
Executive summary:
Six male and 6 female rats per group were exposed to 0.19, 0.32, 0.50, 1.26, 2.24, and 3.02 mg test material/L.

Clinical observations during exposure and twice per day for 14 days after exposure (except holidays and weekends). Body weights recorded at days 0, 1, 7 and 14. Necropsy on found dead and on survivors at day 14. Signs of respiratory irritation, including gasping, rales, hyperpnea, dyspnea and vocalization, were seen in some animals in all groups immediately post-exposure. The number of animals showing these signs and the severity of the respiratory irritation correlated with the concentration of the test material to which the animals were exposed in the report. The signs of respiratory irritation disappeared in all surviving animals, taking from two to twelve days. Small red droplets were seen on the drop sheets in Groups 3, 4, 5, and 6. This sign disappeared in all surviving animals taking from 6 to 12 days. This was judged to be expired nasal exudates and the result of nasal irritation due to exposure of the test substance. Other treatment related signs, including scant feces, thriftlessness and black or crusty material on the muzzle were also seen in several of the groups. The crusty material on the muzzle was judged to be the result of direct contact with the test material. These and all other signs disappeared in all surviving animals by Day 12.

Combined male and female LC50= 2.36 mg Kathon™ 886F per liter of air.

Combined male and female LC50= 0.33 mg a.i. per liter of air.